SCHEMBL12823045

SCHEMBL12823045

CCCc1ccc(-c2ccc(COC3CCC(c4ccc(C5CO5)c(F)c4)CC3)c(F)c2F)cc1

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 4/20 0.35
BRD4 O60885 1/20 0.32
HTR1A P08908 1/20 0.31
MPL P40238 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13586330 0.93 FFAR4 (0.34) FFAR4HTR1AMPL
SCHEMBL12821337 0.93 FFAR4 (0.33) FFAR4BRD4HTR1A
SCHEMBL13654183 0.89 HTR1A (0.34) HTR1A
SCHEMBL12821336 0.88 FFAR4 (0.34) FFAR4HTR1A
SCHEMBL12823375 0.88 FFAR4 (0.34) FFAR4HTR1AMPL
SCHEMBL12821199 0.87 NAAA (0.35) FFAR4HTR1A
SCHEMBL12736767 0.87 FFAR4 (0.40) FFAR4MPL
SCHEMBL13586520 0.87 BRD4 (0.35) FFAR4BRD4MPL
SCHEMBL12736764 0.86 FFAR4 (0.38) FFAR4MPL
SCHEMBL12823365 0.85 PDE4A (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110090450-A1 FOUR-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2011-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110090450-A1 FOUR-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE LEF1, LAS1L, EFHD2 FFAR4 546/4885BRD4 1478/4885HTR1A 484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.